Holding

CSE Bulletin: New Listing - Planet 13 Holdings Inc. 7MAR2029 Warrants (PLTH.WT)

Retrieved on: 
星期四, 三月 7, 2024

Toronto, Ontario--(Newsfile Corp. - Le 7 mars/March 2024) - Planet 13 Holdings Inc. 7MAR2029 Warrants have been approved for listing.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - Le 7 mars/March 2024) - Planet 13 Holdings Inc. 7MAR2029 Warrants have been approved for listing.
  • Each Warrant shall entitle the holder thereof to purchase one common share of the company upon payment of an exercise price of US$0.77, subject to the terms of the warrant agency agreement governing the warrants (the “Warrant Agreement”).
  • Les bons de souscription Planet 13 Holdings Inc. 7MAR2029 ont été approuvés pour la cotation.
  • Voir l'accord de bon de souscription pour tous les détails et conditions.

CSE Bulletin: Symbol Change - New Wave Holdings Corp. (SPOR)

Retrieved on: 
星期一, 二月 26, 2024

Toronto, Ontario--(Newsfile Corp. - Le 26 février/February 2024) - New Wave Holdings Corp. has announced a symbol change to NWAI.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - Le 26 février/February 2024) - New Wave Holdings Corp. has announced a symbol change to NWAI.
  • Shares will begin trading under the new symbol on February 28, 2024.
  • Please note that all open orders will be cancelled at the end of business on February 27, 2024.
  • New Wave Holdings Corp. a annoncé un changement de symbole pour NWAI Les actions commenceront à être négociées sous le nouveau symbole le 28 février 2024.

HKIRA 10th IR Awards 2024 now open for nomination

Retrieved on: 
星期三, 二月 21, 2024

HONG KONG, Feb 21, 2024 - (ACN Newswire) - Hong Kong Investor Relations Association (HKIRA) is pleased to announce that public nomination is now open for the HKIRA 10th IR Awards 2024 (the 'Awards').

Key Points: 
  • HONG KONG, Feb 21, 2024 - (ACN Newswire) - Hong Kong Investor Relations Association (HKIRA) is pleased to announce that public nomination is now open for the HKIRA 10th IR Awards 2024 (the 'Awards').
  • Dr Eva Chan, Founding Chairman of HKIRA, said, "This is the 10th year of the IR Awards launched since 2015.
  • Public nomination for the HKIRA 10th IR Awards 2024 is now open to Hong Kong-listed companies.
  • The HKIRA 10th IR Awards 2024 scheme has a total of 16 award categories honouring best IR practices of individuals and companies.

Blender Bites Announces $2 Million Loan from Export Development Canada

Retrieved on: 
星期一, 三月 11, 2024

VANCOUVER, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Blender Bites Limited (the “Company” or “Blender Bites”) (CSE: BITE, FWB: JL4, WKN: A3DMEJ) is pleased to announce that further to its November 9, 2023 press release, its operating subsidiary, Blender Bites (Holdings) Limited, has entered into a definitive agreement with Export Development Canada (“EDC”) for a term loan credit facility of up to $2,000,000 (the “Facility”).

Key Points: 
  • VANCOUVER, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Blender Bites Limited (the “Company” or “Blender Bites”) (CSE: BITE, FWB: JL4, WKN: A3DMEJ) is pleased to announce that further to its November 9, 2023 press release, its operating subsidiary, Blender Bites (Holdings) Limited, has entered into a definitive agreement with Export Development Canada (“EDC”) for a term loan credit facility of up to $2,000,000 (the “Facility”).
  • “Our expansion into the U.S. market has been instrumental in the Company’s growth, and provides a solid foundation for our long-term success.
  • The Facility is available in three drawdowns within the next six-months, with interest only payments for the first 12-months.
  • The Facility is secured by a security interest over the assets of Blender Bites (Holdings) Ltd. and is guaranteed by the Company and Blender Bites US Ltd.

Bio-Path Holdings Reports Full Year 2023 Financial Results

Retrieved on: 
星期五, 三月 8, 2024

“2023 was a year of focused execution, as evidenced by the continued progress across our pipeline of DNAbilize programs,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings.

Key Points: 
  • “2023 was a year of focused execution, as evidenced by the continued progress across our pipeline of DNAbilize programs,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings.
  • As of December 31, 2023, the Company had cash of $1.1 million, compared to $10.4 million as of December 31, 2022.
  • Net cash provided by financing activities for the year ended December 31, 2023 was $2.2 million.
  • ET to review these full-year 2023 financial results and to provide a general update on the Company.

Investigation Alert Driven Brands Holdings, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

Retrieved on: 
星期二, 三月 5, 2024

Johnson Fistel, LLP is investigating potential claims on behalf of Driven Brands Holdings, Inc. against certain of its officers and directors.

Key Points: 
  • Johnson Fistel, LLP is investigating potential claims on behalf of Driven Brands Holdings, Inc. against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of Apellis Pharmaceuticals against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of Inspire Medical Systems, Inc. against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of Applied Digital Corporation against certain of its officers and directors.

Kirby McInerney LLP is Investigating Potential Shareholder Claims Against WNS (Holdings) Limited (WNS)

Retrieved on: 
星期一, 三月 4, 2024

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that the firm is investigating potential claims against WNS (Holdings) Limited (“WNS” or the “Company”) (NYSE: WNS ).

Key Points: 
  • NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that the firm is investigating potential claims against WNS (Holdings) Limited (“WNS” or the “Company”) (NYSE: WNS ).
  • The firm’s ongoing investigation concerns whether WNS and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On February 2, 2024, WNS disclosed that “one of [WNS’s] top five customers by revenue contribution in fiscal 2024 .
  • Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

A&O Shearman Announces First Senior Leadership Roles

Retrieved on: 
星期五, 三月 1, 2024

London and New York, March 01, 2024 (GLOBE NEWSWIRE) -- Allen & Overy (A&O) and Shearman & Sterling (Shearman) today announced the first of several senior leadership roles for the combined firm A&O Shearman, taking effect on May 1, 2024.

Key Points: 
  • London and New York, March 01, 2024 (GLOBE NEWSWIRE) -- Allen & Overy (A&O) and Shearman & Sterling (Shearman) today announced the first of several senior leadership roles for the combined firm A&O Shearman, taking effect on May 1, 2024.
  • Khalid Garousha has been elected as senior partner and Hervé Ekué has been elected as managing partner of A&O Shearman.
  • Adam Hakki, current senior partner at Shearman, has been appointed co-chair of the global A&O Shearman board and executive committee, and will also lead the firm’s U.S. business as its chair.
  • Khalid Garousha, senior partner, said: “I am honored that the partnership has put its trust in me to lead A&O Shearman as its first senior partner.

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024

Retrieved on: 
星期五, 三月 1, 2024

ET to report financial results for the fourth quarter and full year ended December 31, 2023 and to provide a business overview.

Key Points: 
  • ET to report financial results for the fourth quarter and full year ended December 31, 2023 and to provide a business overview.
  • To access the live conference call, please call (833) 630-1956 (domestic) or (412) 317-1837 (international) at least five minutes prior to the start time.
  • A live audio webcast of the call will also be available on the Presentations section of the Company’s website, www.biopathholdings.com .
  • An archived webcast will be available on the Bio-Path website approximately two hours after the event.

Aegon reports second half year 2023 results

Retrieved on: 
星期五, 三月 1, 2024

Please click here to access all 2H 2023 results related documents.

Key Points: 
  • Please click here to access all 2H 2023 results related documents.
  • Free cash flow amounted to EUR 429 million for the second half of 2023, contributing to a total of EUR 715 million for the year, enabling us to exceed our guidance of EUR 600 million.
  • The IFRS operating result of EUR 681 million was lower than in the second half of 2022, reflecting one-time benefits in 2022 that did not recur in 2023, as well as the impact of announced management actions in 2023.
  • The contrasting trend in our IFRS results compared to our OCG results is caused by differences in the timing of recognition of earnings between the two frameworks.